Leuprorelin Drugs Market Gaining Momentum with Rising Focus on Personalized Hormone Care
The global leuprorelin drugs market is expected to reach US$ 5.1 billion by 2034, rising from US$ 2.9 billion in 2024. The market is projected to grow at a CAGR of 5.8% between 2025 and 2034. Leuprorelin is widely used to manage hormone-related disorders such as prostate cancer, endometriosis, uterine fibroids, early-onset puberty, and infertility. This steady rise in demand is linked to...
0 Commenti 0 Condivisioni 5 Visualizzazioni